Under US president Joe Biden, the Department of Justice has been moving energetically of late to uncover and prosecute offenses that might otherwise have been swept under heavy rugs, including Covid-related API manufacturing contracts won under unclear circumstances.
Last week’s announcement that photography group Eastman Kodak had received a 25-year, $765 million US government loan to produce active pharmaceutical ingredients (APIs) took the market by surprise. The plan was said to be to secure a national emergency supply, in order to reduce dependence on Chinese and Indian imports.
Former photography giant Eastman Kodak is moving into the manufacture of pharmaceutical ingredients, supported by a $765 million government loan awarded by the administration of US president Donald Trump under the Defense Production Act (DPA).
